CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

TCC-COVID mHealth solutionWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug1900 Premier Biotech COVID-19 IgG/IgM Rapid test Cassette Wiki 1.00

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 ReCOVER (Remote COVID-19 Evaluation and Response): a Prospective Non-randomised Controlled Trial to Evaluate the Effect of a Novel Smartphone Application-centric Model of Care for the Remote Monitoring of COVID-19 Patients in the Community.

This is a multi-site, prospective, non-randomised trial assessing the implementation of a smartphone application-based model of care for patients with COVID-19 infection managed in community isolation. We will recruit 2000 COVID +ve patients aged 18 years and over who are managed at home. The objective will be to describe the rates of avoidable presentations to ED and 30 day all case mortality per diagnosed COVID-19 case and to compare these to a propensity matched and synthetic control group.

NCT04399109 COVID Device: TCC-COVID mHealth solution

Primary Outcomes

Description: Definition based on potentially avoidable general practitioner-type presentations as specified in the National Healthcare

Measure: Rate of avoidable Emergency Department presentations per diagnosed COVID-19 case

Time: 12 months

Measure: All cause mortality per diagnosed COVID-19 case All-cause mortality rate at 30 days per diagnosed COVID-19 case

Time: 30 days

Secondary Outcomes

Description: Data linkage to patient medical records

Measure: Rate of hospital admission per diagnosed COVID case

Time: 12 months

Description: Data linkage to MBS database and patient medical records

Measure: Rate of MBS claims for un-referred visits to general practitioners and analogous COVID-19 MBS telehealth items per diagnosed COVID case

Time: 12 months

Description: Data linkage to patient medical records

Measure: Average length of stay (LOS) for admitted patients per diagnosed COVID case

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of admission to Intensive Care Unit (ICU) for admitted patients per diagnosed COVID case

Time: 12 months

Description: Data linkage to patient medical records

Measure: Time from presentation to admission to ICU for patients admitted to ICU per diagnosed COVID case

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of intubation in admitted patients per diagnosed COVID case

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of readmission within 30 days of discharge in admitted patients per diagnosed COVID case

Time: 30 days

Measure: All-cause mortality at 90 days per diagnosed COVID case

Time: 90 days

Description: Data linkage to patient medical records

Measure: Rate of avoidable Emergency Department presentations with COVID-19 diagnosis per 100,000 population, during trial period

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of hospital admission with COVID-19 diagnosis per 100,000 population, during trial period

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of admission to ICU with COVID-19 diagnosis per 100,000 population during trial period

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of mortality with COVID-19 cause of death per 100,000 population, during trial period

Time: 12 months

Description: The feedback questionnaire was designed specifically for this study.

Measure: Qualitative assessment of TCC-COVID app usability via a subjective feedback questionnaire provided to all patients enrolled in the study.

Time: 12 months

Description: From NSW Health data linkage

Measure: Cost-effectiveness of TCC-COVID by measuring the incremental cost per death averted, per ICU admission averted and per length of stay in ICU

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of hospital bed days with COVID-19 diagnosis per 100,000 population, during trial period

Time: 12 months

Description: Data linkage to patient medical records

Measure: Rate of ICU bed days with COVID-19 diagnosis per 100,000 population, during trial period

Time: 12 months

Description: Completed by all physicians and research nurses entering data into the portal and monitoring patients throughout the study. The feedback questionnaire was designed specifically for this study.

Measure: Qualitative assessment of KIOLA physician portal usability via a subjective feedback questionnaire

Time: 12 months

No related HPO nodes (Using clinical trials)